Medline Inc. Research and Development Expense
Medline Inc. (MDLN) reported Research and Development Expense of $80.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-02-25
- Medline Inc. research and development expense for fiscal 2025 was $80.00M, a 19.40% increase from fiscal 2024.
- Medline Inc. research and development expense for fiscal 2024 was $67.00M, a 11.67% increase from fiscal 2023.
- Medline Inc. research and development expense for fiscal 2023 was $60.00M.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $80.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | $67.00M 10-K · filed 2026-02-25 |
| 2023-12-31 | $60.00M 10-K · filed 2026-02-25 |